| Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis ME Wechsler, P Akuthota, D Jayne, P Khoury, A Klion, CA Langford, ... New England Journal of Medicine 376 (20), 1921-1932, 2017 | 823 | 2017 |
| Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes P Valent, AD Klion, HP Horny, F Roufosse, J Gotlib, PF Weller, ... Journal of Allergy and Clinical Immunology 130 (3), 607-612. e9, 2012 | 809 | 2012 |
| Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources S Köhler, L Carmody, N Vasilevsky, JOB Jacobsen, D Danis, JP Gourdine, ... Nucleic acids research 47 (D1), D1018-D1027, 2019 | 669 | 2019 |
| Treatment of patients with the hypereosinophilic syndrome with mepolizumab ME Rothenberg, AD Klion, FE Roufosse, JE Kahn, PF Weller, HU Simon, ... New England Journal of Medicine 358 (12), 1215-1228, 2008 | 661 | 2008 |
| Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy PU Ogbogu, BS Bochner, JH Butterfield, GJ Gleich, J Huss-Marp, JE Kahn, ... Journal of Allergy and Clinical Immunology 124 (6), 1319-1325. e3, 2009 | 656 | 2009 |
| The role of eosinophils in host defense against helminth parasites AD Klion, TB Nutman Journal of Allergy and Clinical Immunology 113 (1), 30-37, 2004 | 547 | 2004 |
| Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor … AD Klion, P Noel, C Akin, MA Law, DG Gilliland, J Cools, DD Metcalfe, ... Blood 101 (12), 4660-4666, 2003 | 431 | 2003 |
| Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report AD Klion, BS Bochner, GJ Gleich, TB Nutman, ME Rothenberg, HU Simon, ... Journal of Allergy and Clinical Immunology 117 (6), 1292-1302, 2006 | 406 | 2006 |
| Refining the definition of hypereosinophilic syndrome HU Simon, ME Rothenberg, BS Bochner, PF Weller, AJ Wardlaw, ... Journal of allergy and clinical immunology 126 (1), 45-49, 2010 | 371 | 2010 |
| Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome AD Klion, J Robyn, C Akin, P Noel, M Brown, M Law, DD Metcalfe, ... Blood 103 (2), 473-478, 2004 | 286 | 2004 |
| The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan JJ Kotzin, SP Spencer, SJ McCright, DBU Kumar, MA Collet, WK Mowel, ... Nature 537 (7619), 239-243, 2016 | 262 | 2016 |
| How I treat hypereosinophilic syndromes AD Klion Blood, The Journal of the American Society of Hematology 126 (9), 1069-1077, 2015 | 236 | 2015 |
| Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes FE Roufosse, JE Kahn, GJ Gleich, LB Schwartz, AD Singh, ... Journal of allergy and clinical immunology 131 (2), 461-467. e5, 2013 | 229 | 2013 |
| A new dawn for eosinophils in the tumour microenvironment S Grisaru-Tal, M Itan, AD Klion, A Munitz Nature Reviews Cancer 20 (10), 594-607, 2020 | 206 | 2020 |
| Anti–Siglec-8 antibody for eosinophilic gastritis and duodenitis ES Dellon, KA Peterson, JA Murray, GW Falk, N Gonsalves, M Chehade, ... New England Journal of Medicine 383 (17), 1624-1634, 2020 | 188 | 2020 |
| Contributions of eosinophils to human health and disease AD Klion, SJ Ackerman, BS Bochner Annual Review of Pathology: Mechanisms of Disease 15, 179-209, 2020 | 185 | 2020 |
| Loiasis in endemic and nonendemic populations: immunologically mediated differences in clinical presentation AD Klion, A Massougbodji, BC Sadeler, EA Ottesen, TB Nutman Journal of Infectious Diseases 163 (6), 1318-1325, 1991 | 185 | 1991 |
| Novel targeted therapies for eosinophilic disorders ME Wechsler, PC Fulkerson, BS Bochner, GM Gauvreau, GJ Gleich, ... Journal of allergy and clinical immunology 130 (3), 563-571, 2012 | 180 | 2012 |
| Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field P Valent, GJ Gleich, A Reiter, F Roufosse, PF Weller, A Hellmann, ... Expert review of hematology 5 (2), 157-176, 2012 | 175 | 2012 |
| Safety and efficacy of the monoclonal anti–interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome AD Klion, MA Law, P Noel, YJ Kim, TP Haverty, TB Nutman Blood 103 (8), 2939-2941, 2004 | 175 | 2004 |
